
Brain Monitoring Market Analysis and Forecast to 2031: By Product Type (Electroencephalography Devices, Magnetencephalography Devices, Transcranial Doppler Devices, Intracranial Pressure Monitor, Cerebral Oximeters, Magnetic Resonance Imaging Devices, Com
Description
Brain Monitoring Market Analysis and Forecast to 2031: By Product Type (Electroencephalography Devices, Magnetencephalography Devices, Transcranial Doppler Devices, Intracranial Pressure Monitor, Cerebral Oximeters, Magnetic Resonance Imaging Devices, Computerized Tomography Devices, Positron Emission Tomography Devices, Sleep Monitoring Devices, Electromyography Devices, Accessories), Procedure (Invasive, Non-invasive), Application (Epilepsy, Dementia, Parkinson’s Disease, Huntington’s Disease, Headache Disorders, Stroke, Traumatic Brain Injuries, Sleep Disorders, Other Diseases), and Region
The global brain monitoring market size was USD 5.4 billion in 2021 and it is anticipated to reach USD 10.1 billion in 2031, growing at a rate of 7.2% from 2022-2031.
Brain monitoring helps clinicians in monitoring the condition of the brain under the influence of anesthesia through bilateral data acquisition and processing of the EEG signals. Brain monitoring devices are used to monitor and diagnose neurological conditions by exploring the structure and function of the brain. This process involves the use of several brain monitoring devices. At present, there is an increase in the demand for electroencephalography devices among healthcare providers.
Brain Monitoring Market Scope and Structure Analysis
Market Trends and Drivers
The major factor boosting the growth of the market is the increasing incidence and prevalence of neurological disorders. The global incidence and prevalence of neurological disorders, like dementia, epilepsy, Parkinson’s disease, Huntington’s disease, headache disorders, multiple sclerosis, neuro infections, stroke, and cerebral palsy, have increased significantly during the last few years. Brain disorders, which comprise a combination of developmental, psychiatric, and neurodegenerative diseases, are a growing cause of morbidity worldwide. This can mainly be attributed to the growing geriatric population (by 2050, more than 20% of the global population is expected to be aged over 65 years). The American Medical Association (AMA) anticipates that at least 60% of individuals aged 65 years and above will be living with more than one chronic condition by 2030.
The rising incidences of these neurological disorders have made it extremely important to monitor brain and neurological function. Many neurological disorders and conditions are progressive, and their risk increases with age. Adding to that, the prevalence of other diseases and conditions, such as sickle-cell diseases and cardiac disorders, is also increasing. Cardiac procedures may sometimes affect the normal functioning of the brain, which is another factor driving the demand for brain monitoring devices.
Market Restraints & Challenges
One of the primary challenges in the growth of the global brain monitoring market is the high cost of complex brain monitoring procedures and devices. The high cost of brain monitoring surgeries and devices is a primary factor restraining the global brain monitoring market, majorly in developing countries with poor reimbursement policies. Brain monitoring devices are highly complex, and the procedures involving the use of these devices are generally expensive. For example, the average cost of a standard EEG is ~USD 200–700; this procedure can cost as high as USD 3,000 for extended monitoring. A dual-channel TCD costs approximately USD 3,000–3,200, and an ICP monitor costs approximately USD 340–500. Similarly, a single MEG system costs roughly USD 2.5–3 million. Owing to the high price, healthcare facilities, even in countries that show wide adoption of high-tech medical equipment, find it difficult to procure MEG devices. Moreover, the maintenance cost and other associated indirect expenses increase the total cost of ownership of these devices, so limiting their adoption.
Global Brain Monitoring Market Segmentation
The report analyses the brain monitoring market based on product type, procedure, application, and region.
Global Brain Monitoring Market by Product Type
On the basis of product type, it is segmented into electroencephalography devices, magnetoencephalography devices, transcranial doppler devices, intracranial pressure monitors, cerebral oximeters, magnetic resonance imaging devices, computerized tomography devices, sleep monitoring devices, electromyography devices, and accessories. The electroencephalography devices segment is likely to dominate the market during the forecast period. The surge in demand for the diagnosis of critical disorders such as epilepsy has further influenced companies to focus on the development of brain monitoring EEG devices.
Global Brain Monitoring Market by Procedure
On the basis of procedure, it is segmented into invasive and non-invasive. The non-invasive segment accounted for the fastest growth during the forecast period. The key factors such as rise in incidences of traumatic brain injuries coupled with a high acceptance rate of minimally invasive devices, and a low risk of mortality. This increases the demand for these products which propels the market growth.
Global Brain Monitoring Market by Application
On the basis of application, it is segmented into epilepsy, dementia, parkinson’s disease, huntington’s disease, headache disorders, stroke, traumatic brain injuries, sleep disorders, and other diseases. The epilepsy segment is anticipated to dominate the market during the forecast period. The key factors such as the increasing geriatric population and the rise in the prevalence of neurological disorders are boosting the growth of the market.
Geographical Analysis of Global Brain Monitoring Market
Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America accounted for the largest share of the global brain monitoring market. The key factors such as growing incidences of neurological diseases, a growing number of clinical trials of brain monitoring products, and the availability of medical reimbursement in the US.
Major Players of the Global Brain Monitoring Market
COVID-19 Analysis
The state of urgency to combat the outbreak has led to a significant increase in the demand for remote monitoring and patient engagement solutions. Most hospitals/healthcare facilities are currently trying to expand patient monitoring to home care settings or other temporary setups with an aim to provide optimal care. COVID-19 has led to a significant surge in demand for ventilators, and manufacturers are currently focusing their efforts to meet the increasing need for ventilators. Comprising other respiratory devices, in contrast to the brain monitoring business, particularly owing to the focus of hospitals on setting up COVID-19 specific ICUs, along with the temporary suspension of manufacturing sites in highly affected regions worldwide.
Recent Developments
Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.
The global brain monitoring market size was USD 5.4 billion in 2021 and it is anticipated to reach USD 10.1 billion in 2031, growing at a rate of 7.2% from 2022-2031.
Brain monitoring helps clinicians in monitoring the condition of the brain under the influence of anesthesia through bilateral data acquisition and processing of the EEG signals. Brain monitoring devices are used to monitor and diagnose neurological conditions by exploring the structure and function of the brain. This process involves the use of several brain monitoring devices. At present, there is an increase in the demand for electroencephalography devices among healthcare providers.
Brain Monitoring Market Scope and Structure Analysis
Market Trends and Drivers
The major factor boosting the growth of the market is the increasing incidence and prevalence of neurological disorders. The global incidence and prevalence of neurological disorders, like dementia, epilepsy, Parkinson’s disease, Huntington’s disease, headache disorders, multiple sclerosis, neuro infections, stroke, and cerebral palsy, have increased significantly during the last few years. Brain disorders, which comprise a combination of developmental, psychiatric, and neurodegenerative diseases, are a growing cause of morbidity worldwide. This can mainly be attributed to the growing geriatric population (by 2050, more than 20% of the global population is expected to be aged over 65 years). The American Medical Association (AMA) anticipates that at least 60% of individuals aged 65 years and above will be living with more than one chronic condition by 2030.
The rising incidences of these neurological disorders have made it extremely important to monitor brain and neurological function. Many neurological disorders and conditions are progressive, and their risk increases with age. Adding to that, the prevalence of other diseases and conditions, such as sickle-cell diseases and cardiac disorders, is also increasing. Cardiac procedures may sometimes affect the normal functioning of the brain, which is another factor driving the demand for brain monitoring devices.
Market Restraints & Challenges
One of the primary challenges in the growth of the global brain monitoring market is the high cost of complex brain monitoring procedures and devices. The high cost of brain monitoring surgeries and devices is a primary factor restraining the global brain monitoring market, majorly in developing countries with poor reimbursement policies. Brain monitoring devices are highly complex, and the procedures involving the use of these devices are generally expensive. For example, the average cost of a standard EEG is ~USD 200–700; this procedure can cost as high as USD 3,000 for extended monitoring. A dual-channel TCD costs approximately USD 3,000–3,200, and an ICP monitor costs approximately USD 340–500. Similarly, a single MEG system costs roughly USD 2.5–3 million. Owing to the high price, healthcare facilities, even in countries that show wide adoption of high-tech medical equipment, find it difficult to procure MEG devices. Moreover, the maintenance cost and other associated indirect expenses increase the total cost of ownership of these devices, so limiting their adoption.
Global Brain Monitoring Market Segmentation
The report analyses the brain monitoring market based on product type, procedure, application, and region.
Global Brain Monitoring Market by Product Type
On the basis of product type, it is segmented into electroencephalography devices, magnetoencephalography devices, transcranial doppler devices, intracranial pressure monitors, cerebral oximeters, magnetic resonance imaging devices, computerized tomography devices, sleep monitoring devices, electromyography devices, and accessories. The electroencephalography devices segment is likely to dominate the market during the forecast period. The surge in demand for the diagnosis of critical disorders such as epilepsy has further influenced companies to focus on the development of brain monitoring EEG devices.
Global Brain Monitoring Market by Procedure
On the basis of procedure, it is segmented into invasive and non-invasive. The non-invasive segment accounted for the fastest growth during the forecast period. The key factors such as rise in incidences of traumatic brain injuries coupled with a high acceptance rate of minimally invasive devices, and a low risk of mortality. This increases the demand for these products which propels the market growth.
Global Brain Monitoring Market by Application
On the basis of application, it is segmented into epilepsy, dementia, parkinson’s disease, huntington’s disease, headache disorders, stroke, traumatic brain injuries, sleep disorders, and other diseases. The epilepsy segment is anticipated to dominate the market during the forecast period. The key factors such as the increasing geriatric population and the rise in the prevalence of neurological disorders are boosting the growth of the market.
Geographical Analysis of Global Brain Monitoring Market
Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America accounted for the largest share of the global brain monitoring market. The key factors such as growing incidences of neurological diseases, a growing number of clinical trials of brain monitoring products, and the availability of medical reimbursement in the US.
Major Players of the Global Brain Monitoring Market
COVID-19 Analysis
The state of urgency to combat the outbreak has led to a significant increase in the demand for remote monitoring and patient engagement solutions. Most hospitals/healthcare facilities are currently trying to expand patient monitoring to home care settings or other temporary setups with an aim to provide optimal care. COVID-19 has led to a significant surge in demand for ventilators, and manufacturers are currently focusing their efforts to meet the increasing need for ventilators. Comprising other respiratory devices, in contrast to the brain monitoring business, particularly owing to the focus of hospitals on setting up COVID-19 specific ICUs, along with the temporary suspension of manufacturing sites in highly affected regions worldwide.
Recent Developments
- September 2021, NeuroWave Systems Inc. announced the FDA clearance of its Neuro SENSE NS-901 Monitor- a new generation brain function monitor for assessing the adequacy of anesthesia and sedation in clinical settings.
- November 2021, Brain Scientific received FDA clearance for Next-Gen Neuro Cap EEG Headset, and advanced electroencephalogram electrodes array used to obtain rapid EEG’s in routine clinical and research settings where the recording of STAT EEG’s is desired.
- February 2020, Compumedics announced milestone US FDA approval for the Orion Life Span MEG.
- The report offers a comprehensive quantitative as well as qualitative analysis of the current global brain monitoring market outlook and estimations from 2021 to 2031, which helps to recognize the prevalent opportunities.
- A thorough analysis of aspects that boost and restrict the development of the market is provided.
- Region-wise, as well as country-wise conditions, are broadly evaluated in this report.
- The forecasts in this report are made by examining the recent trends along with future brain monitoring market potential from 2021 to 2031 in terms of revenue.
- Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the global brain monitoring industry.
Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.
Table of Contents
167 Pages
- MARKET INTRODUCTION
- OBJECTIVES OF THE STUDY
- MARKET DEFINITION AND RESEARCH & SCOPE
- RESEARCH METHODOLOGIES
- MARKET ESTIMATION TECHNIQUES
- EXECUTIVE SUMMARY
- SUMMARY
- KEY HIGHLIGHTS OF THE MARKET
- BLOOD SCREENING MARKET OUTLOOK
- BLOOD SCREENING MARKET SEGMENTATION
- MARKET DYNAMICS
- MARKET DRIVERS
- DRIVER 1
- DRIVER 2
- DRIVER 3
- MARKET RESTRAINTS
- RESTRAINT 1
- RESTRAINT 2
- MARKET OPPORTUNITIES
- OPPORTUNITY 1
- OPPORTUNITY 2
- PORTER’S FIVE FORCES ANALYSIS
- THREAT OF NEW ENTRANTS
- THREAT OF SUBSTITUTES
- BARGAINING POWER OF BUYERS
- BARGAINING POWER OF SUPPLIER
- COMPETITIVE RIVALRY
- PESTLE ANALYSIS
- VALUE CHAIN ANALYSIS
- RAW MATERIAL SUPPLIERS
- MANUFACTURERS
- WHOLESALERS AND/OR RETAILERS
- IMPACT OF RUSSIA AND UKRAINE WAR ON THE GLOBAL BLOOD SCREENING MARKET
- ECONOMIC IMPACT OF COVID-19
- OVERALL IMPACT OF COVID-19
- IMPACT OF COVID ON THE GLOBAL BLOOD SCREENING MARKET
- ECONOMIC IMPACT ANALYSIS
- BLOOD SCREENING MARKET BY PRODUCT AND SERVICES
- MARKET OVERVIEW
- REAGENTS & KITS
- MARKET SIZE AND FORECAST, 2021-2031 ($MILLION)
- MARKET SIZE AND FORECAST, BY REGION, 2021-2031 ($MILLION)
- INSTRUMENTS
- MARKET SIZE AND FORECAST, 2021-2031 ($MILLION)
- MARKET SIZE AND FORECAST, BY REGION, 2021-2031 ($MILLION)
- SOFTWARE & SERVICES
- MARKET SIZE AND FORECAST, 2021-2031 ($MILLION)
- MARKET SIZE AND FORECAST, BY REGION, 2021-2031 ($MILLION)
- BLOOD SCREENING MARKET BY TECHNOLOGY
- MARKET OVERVIEW
- NUCLEIC ACID TEST
- MARKET SIZE AND FORECAST, 2021-2031 ($MILLION)
- MARKET SIZE AND FORECAST, BY REGION, 2021-2031 ($MILLION)
- ELISA
- MARKET SIZE AND FORECAST, 2021-2031 ($MILLION)
- MARKET SIZE AND FORECAST, BY REGION, 2021-2031 ($MILLION)
- RAPID TESTS
- MARKET SIZE AND FORECAST, 2021-2031 ($MILLION)
- MARKET SIZE AND FORECAST, BY REGION, 2021-2031 ($MILLION)
- WESTERN BLOT ASSAYS
- MARKET SIZE AND FORECAST, 2021-2031 ($MILLION)
- MARKET SIZE AND FORECAST, BY REGION, 2021-2031 ($MILLION)
- NEXT-GENERATION SEQUENCING
- MARKET SIZE AND FORECAST, 2021-2031 ($MILLION)
- MARKET SIZE AND FORECAST, BY REGION, 2021-2031 ($MILLION)
- BLOOD SCREENING MARKET BY END USER
- MARKET OVERVIEW
- BLOOD BANKS
- MARKET SIZE AND FORECAST, 2021-2031 ($MILLION)
- MARKET SIZE AND FORECAST, BY REGION, 2021-2031 ($MILLION)
- HOSPITALS
- MARKET SIZE AND FORECAST, 2021-2031 ($MILLION)
- MARKET SIZE AND FORECAST, BY REGION, 2021-2031 ($MILLION)
- BLOOD SCREENING MARKET, BY REGION
- OVERVIEW
- NORTH AMERICA
- KEY MARKET TRENDS AND OPPORTUNITIES
- NORTH AMERICA BLOOD SCREENING MARKET SIZE AND FORECAST BY MATERIAL, 2021-2031, ($MILLION)
- NORTH AMERICA BLOOD SCREENING MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
- NORTH AMERICA BLOOD SCREENING MARKET SIZE AND FORECAST BY PLACEMENT, 2021-2031, ($MILLION)
- NORTH AMERICA BLOOD SCREENING MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
- NORTH AMERICA BLOOD SCREENING MARKET SIZE AND FORECAST BY COUNTRY, 2021-2031, ($MILLION)
- THE U.S.
- THE U.S. BLOOD SCREENING MARKET SIZE AND FORECAST BY MATERIAL, 2021-2031, ($MILLION)
- THE U.S. BLOOD SCREENING MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
- THE U.S. BLOOD SCREENING MARKET SIZE AND FORECAST BY PLACEMENT, 2021-2031, ($MILLION)
- THE U.S. BLOOD SCREENING MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
- CANADA
- CANADA BLOOD SCREENING MARKET SIZE AND FORECAST BY MATERIAL, 2021-2031, ($MILLION)
- CANADA BLOOD SCREENING MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
- CANADA BLOOD SCREENING MARKET SIZE AND FORECAST BY PLACEMENT, 2021-2031, ($MILLION)
- CANADA BLOOD SCREENING MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
- MEXICO
- MEXICO BLOOD SCREENING MARKET SIZE AND FORECAST BY MATERIAL, 2021-2031, ($MILLION)
- MEXICO BLOOD SCREENING MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
- MEXICO BLOOD SCREENING MARKET SIZE AND FORECAST BY PLACEMENT, 2021-2031, ($MILLION)
- MEXICO BLOOD SCREENING MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
- EUROPE
- KEY MARKET TRENDS AND OPPORTUNITIES
- EUROPE BLOOD SCREENING MARKET SIZE AND FORECAST BY MATERIAL, 2021-2031, ($MILLION)
- EUROPE BLOOD SCREENING MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
- EUROPE BLOOD SCREENING MARKET SIZE AND FORECAST BY PLACEMENT, 2021-2031, ($MILLION)
- EUROPE BLOOD SCREENING MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
- EUROPE BLOOD SCREENING MARKET SIZE AND FORECAST BY COUNTRY, 2021-2031, ($MILLION)
- GERMANY
- GERMANY BLOOD SCREENING MARKET SIZE AND FORECAST BY MATERIAL, 2021-2031, ($MILLION)
- GERMANY BLOOD SCREENING MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
- GERMANY BLOOD SCREENING MARKET SIZE AND FORECAST BY PLACEMENT, 2021-2031, ($MILLION)
- GERMANY BLOOD SCREENING MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
- FRANCE
- FRANCE BLOOD SCREENING MARKET SIZE AND FORECAST BY MATERIAL, 2021-2031, ($MILLION)
- FRANCE BLOOD SCREENING MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
- FRANCE BLOOD SCREENING MARKET SIZE AND FORECAST BY PLACEMENT, 2021-2031, ($MILLION)
- FRANCE BLOOD SCREENING MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
- U.K.
- U.K. BLOOD SCREENING MARKET SIZE AND FORECAST BY MATERIAL, 2021-2031, ($MILLION)
- U.K. BLOOD SCREENING MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
- U.K. BLOOD SCREENING MARKET SIZE AND FORECAST BY PLACEMENT, 2021-2031, ($MILLION)
- U.K. BLOOD SCREENING MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
- SPAIN
- SPAIN BLOOD SCREENING MARKET SIZE AND FORECAST BY MATERIAL, 2021-2031, ($MILLION)
- SPAIN BLOOD SCREENING MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
- SPAIN BLOOD SCREENING MARKET SIZE AND FORECAST BY PLACEMENT, 2021-2031, ($MILLION)
- SPAIN BLOOD SCREENING MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
- ITALY
- ITALY BLOOD SCREENING MARKET SIZE AND FORECAST BY MATERIAL, 2021-2031, ($MILLION)
- ITALY BLOOD SCREENING MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
- ITALY BLOOD SCREENING MARKET SIZE AND FORECAST BY PLACEMENT, 2021-2031, ($MILLION)
- ITALY BLOOD SCREENING MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
- RUSSIA
- RUSSIA BLOOD SCREENING MARKET SIZE AND FORECAST BY MATERIAL, 2021-2031, ($MILLION)
- RUSSIA BLOOD SCREENING MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
- RUSSIA BLOOD SCREENING MARKET SIZE AND FORECAST BY PLACEMENT, 2021-2031, ($MILLION)
- RUSSIA BLOOD SCREENING MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
- REST OF EUROPE
- REST OF EUROPE BLOOD SCREENING MARKET SIZE AND FORECAST BY MATERIAL, 2021-2031, ($MILLION)
- REST OF EUROPE BLOOD SCREENING MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
- REST OF EUROPE BLOOD SCREENING MARKET SIZE AND FORECAST BY PLACEMENT, 2021-2031, ($MILLION)
- REST OF EUROPE BLOOD SCREENING MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
- ASIA-PACIFIC
- KEY MARKET TRENDS AND OPPORTUNITIES
- ASIA-PACIFIC BLOOD SCREENING MARKET SIZE AND FORECAST BY COUNTRY, 2021-2031, ($MILLION)
- ASIA-PACIFIC BLOOD SCREENING MARKET SIZE AND FORECAST BY MATERIAL, 2021-2031, ($MILLION)
- ASIA-PACIFIC BLOOD SCREENING MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
- ASIA-PACIFIC BLOOD SCREENING MARKET SIZE AND FORECAST BY PLACEMENT, 2021-2031, ($MILLION)
- ASIA-PACIFIC BLOOD SCREENING MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
- CHINA
- CHINA BLOOD SCREENING MARKET SIZE AND FORECAST BY MATERIAL, 2021-2031, ($MILLION)
- CHINA BLOOD SCREENING MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
- CHINA BLOOD SCREENING MARKET SIZE AND FORECAST BY PLACEMENT, 2021-2031, ($MILLION)
- CHINA BLOOD SCREENING MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
- INDIA
- INDIA BLOOD SCREENING MARKET SIZE AND FORECAST BY MATERIAL, 2021-2031, ($MILLION)
- INDIA BLOOD SCREENING MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
- INDIA BLOOD SCREENING MARKET SIZE AND FORECAST BY PLACEMENT, 2021-2031, ($MILLION)
- INDIA BLOOD SCREENING MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
- JAPAN
- JAPAN BLOOD SCREENING MARKET SIZE AND FORECAST BY MATERIAL, 2021-2031, ($MILLION)
- JAPAN BLOOD SCREENING MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
- JAPAN BLOOD SCREENING MARKET SIZE AND FORECAST BY PLACEMENT, 2021-2031, ($MILLION)
- JAPAN BLOOD SCREENING MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
- SOUTH KOREA
- SOUTH KOREA BLOOD SCREENING MARKET SIZE AND FORECAST BY MATERIAL, 2021-2031, ($MILLION)
- SOUTH KOREA BLOOD SCREENING MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
- SOUTH KOREA BLOOD SCREENING MARKET SIZE AND FORECAST BY PLACEMENT, 2021-2031, ($MILLION)
- SOUTH KOREA BLOOD SCREENING MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
- REST OF APAC
- REST OF APAC BLOOD SCREENING MARKET SIZE AND FORECAST BY MATERIAL, 2021-2031, ($MILLION)
- REST OF APAC BLOOD SCREENING MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
- REST OF APAC BLOOD SCREENING MARKET SIZE AND FORECAST BY PLACEMENT, 2021-2031, ($MILLION)
- REST OF APAC BLOOD SCREENING MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
- REST OF THE WORLD
- KEY MARKET TRENDS AND OPPORTUNITIES
- REST OF THE WORLD BLOOD SCREENING MARKET SIZE AND FORECAST BY MATERIAL, 2021-2031, ($MILLION)
- REST OF THE WORLD BLOOD SCREENING MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
- REST OF THE WORLD BLOOD SCREENING MARKET SIZE AND FORECAST BY PLACEMENT, 2021-2031, ($MILLION)
- REST OF THE WORLD BLOOD SCREENING MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
- REST OF THE WORLD BLOOD SCREENING MARKET SIZE AND FORECAST BY COUNTRY, 2021-2031, ($MILLION)
- LATIN AMERICA
- LATIN AMERICA BLOOD SCREENING MARKET SIZE AND FORECAST BY MATERIAL, 2021-2031, ($MILLION)
- LATIN AMERICA BLOOD SCREENING MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
- LATIN AMERICA BLOOD SCREENING MARKET SIZE AND FORECAST BY PLACEMENT, 2021-2031, ($MILLION)
- LATIN AMERICA BLOOD SCREENING MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
- MIDDLE EAST
- MIDDLE EAST BLOOD SCREENING MARKET SIZE AND FORECAST BY MATERIAL, 2021-2031, ($MILLION)
- MIDDLE EAST BLOOD SCREENING MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
- MIDDLE EAST BLOOD SCREENING MARKET SIZE AND FORECAST BY PLACEMENT, 2021-2031, ($MILLION)
- MIDDLE EAST BLOOD SCREENING MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
- AFRICA
- AFRICA BLOOD SCREENING MARKET SIZE AND FORECAST BY MATERIAL, 2021-2031, ($MILLION)
- AFRICA BLOOD SCREENING MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
- AFRICA BLOOD SCREENING MARKET SIZE AND FORECAST BY PLACEMENT, 2021-2031, ($MILLION)
- AFRICA BLOOD SCREENING MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
- COMPETITIVE LANDSCAPE
- MARKET OVERVIEW
- MARKET SHARE ANALYSIS/KEY PLAYER POSITIONING
- DEVELOPMENTAL STRATEGY BENCHMARKING
- NEW PRODUCT DEVELOPMENT
- PRODUCT LAUNCHES
- BUSINESS EXPANSIONS
- PARTNERSHIPS, JOINT VENTURES, AND COLLABORATIONS
- MERGERS AND ACQUISITIONS
- COMPANY PROFILES
- Grifols (Spain)
- COMPANY SNAPSHOT
- FINANCIAL PERFORMANCE
- PRODUCT OFFERINGS
- KEY STRATEGIC INITIATIVES
- SWOT ANALYSIS
- F. Hoffmann-La Roche Ltd. (Switzerland)
- COMPANY SNAPSHOT
- FINANCIAL PERFORMANCE
- PRODUCT OFFERINGS
- KEY STRATEGIC INITIATIVES
- SWOT ANALYSIS
- Abbott Laboratories, Inc. (US)
- COMPANY SNAPSHOT
- FINANCIAL PERFORMANCE
- PRODUCT OFFERINGS
- KEY STRATEGIC INITIATIVES
- SWOT ANALYSIS
- bioMérieux (France)
- COMPANY SNAPSHOT
- FINANCIAL PERFORMANCE
- PRODUCT OFFERINGS
- KEY STRATEGIC INITIATIVES
- SWOT ANALYSIS
- Bio-Rad Laboratories, Inc. (US)
- COMPANY SNAPSHOT
- FINANCIAL PERFORMANCE
- PRODUCT OFFERINGS
- KEY STRATEGIC INITIATIVES
- SWOT ANALYSIS
- Becton, Dickinson and Company (US)
- COMPANY SNAPSHOT
- FINANCIAL PERFORMANCE
- PRODUCT OFFERINGS
- KEY STRATEGIC INITIATIVES
- SWOT ANALYSIS
- Beckman Coulter, Inc. (Danaher) (US)
- COMPANY SNAPSHOT
- FINANCIAL PERFORMANCE
- PRODUCT OFFERINGS
- KEY STRATEGIC INITIATIVES
- SWOT ANALYSIS
- DiaSorin (Italy)
- COMPANY SNAPSHOT
- FINANCIAL PERFORMANCE
- PRODUCT OFFERINGS
- KEY STRATEGIC INITIATIVES
- SWOT ANALYSIS
- Siemens Healthineers (Germany)
- COMPANY SNAPSHOT
- FINANCIAL PERFORMANCE
- PRODUCT OFFERINGS
- KEY STRATEGIC INITIATIVES
- SWOT ANALYSIS
- Thermo Fisher Scientific, Inc. (US)
- COMPANY SNAPSHOT
- FINANCIAL PERFORMANCE
- PRODUCT OFFERINGS
- KEY STRATEGIC INITIATIVES
- SWOT ANALYSIS
- Ortho Clinical Diagnostics Inc. (US)
- COMPANY SNAPSHOT
- FINANCIAL PERFORMANCE
- PRODUCT OFFERINGS
- KEY STRATEGIC INITIATIVES
- SWOT ANALYSIS
- GE Healthcare (US)
- COMPANY SNAPSHOT
- FINANCIAL PERFORMANCE
- PRODUCT OFFERINGS
- KEY STRATEGIC INITIATIVES
- SWOT ANALYSIS
- Merck KGaA (Germany)
- COMPANY SNAPSHOT
- FINANCIAL PERFORMANCE
- PRODUCT OFFERINGS
- KEY STRATEGIC INITIATIVES
- SWOT ANALYSIS
- PerkinElmer (US)
- COMPANY SNAPSHOT
- FINANCIAL PERFORMANCE
- PRODUCT OFFERINGS
- KEY STRATEGIC INITIATIVES
- SWOT ANALYSIS
- Bio-Techne Corporation (US)
- COMPANY SNAPSHOT
- FINANCIAL PERFORMANCE
- PRODUCT OFFERINGS
- KEY STRATEGIC INITIATIVES
- SWOT ANALYSIS
- GFE (Germany)
- COMPANY SNAPSHOT
- FINANCIAL PERFORMANCE
- PRODUCT OFFERINGS
- KEY STRATEGIC INITIATIVES
- SWOT ANALYSIS
- Trinity Biotech (Ireland)
- COMPANY SNAPSHOT
- FINANCIAL PERFORMANCE
- PRODUCT OFFERINGS
- KEY STRATEGIC INITIATIVES
- SWOT ANALYSIS
- Mindray (China)
- COMPANY SNAPSHOT
- FINANCIAL PERFORMANCE
- PRODUCT OFFERINGS
- KEY STRATEGIC INITIATIVES
- SWOT ANALYSIS
- Maccura Biotechnology Co., Ltd. (China)
- COMPANY SNAPSHOT
- FINANCIAL PERFORMANCE
- PRODUCT OFFERINGS
- KEY STRATEGIC INITIATIVES
- SWOT ANALYSIS
- Immucor, Inc. (US)
- COMPANY SNAPSHOT
- FINANCIAL PERFORMANCE
- PRODUCT OFFERINGS
- KEY STRATEGIC INITIATIVES
- SWOT ANALYSIS
- Cellabs (Australia)
- COMPANY SNAPSHOT
- FINANCIAL PERFORMANCE
- PRODUCT OFFERINGS
- KEY STRATEGIC INITIATIVES
- SWOT ANALYSIS
- Abnova Corporation (Taiwan)
- COMPANY SNAPSHOT
- FINANCIAL PERFORMANCE
- PRODUCT OFFERINGS
- KEY STRATEGIC INITIATIVES
- SWOT ANALYSIS
- Enzo Biochem, Inc. (US)
- COMPANY SNAPSHOT
- FINANCIAL PERFORMANCE
- PRODUCT OFFERINGS
- KEY STRATEGIC INITIATIVES
- SWOT ANALYSIS
- Cepheid (US)
- COMPANY SNAPSHOT
- FINANCIAL PERFORMANCE
- PRODUCT OFFERINGS
- KEY STRATEGIC INITIATIVES
- SWOT ANALYSIS
- *The list of company is subject to change during the final compilation of the report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.